↓ Skip to main content

Dove Medical Press

Article Metrics

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report

Overview of attention for article published in Neuropsychiatric Disease and Treatment, November 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley
Title
Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
Published in
Neuropsychiatric Disease and Treatment, November 2017
DOI 10.2147/ndt.s148616
Pubmed ID
Authors

Kosuke Okazaki, Kazuhiko Yamamuro, Toshifumi Kishimoto

Abstract

Antipsychotics are effective for treating schizophrenia, but atypical antipsychotics can cause several adverse side effects including weight gain, hyperprolactinemia, and extrapyramidal symptoms. Moreover, weight gain increases the risk of metabolic diseases. We treated a case of olanzapine-induced weight gain in a 41-year-old man with schizophrenia by switching his medication from olanzapine to asenapine. The weight gain improved after switching the medication, from 80.3 to 75.0 kg, a weight loss of 6.6%, and there was no significant worsening of psychological symptoms or other adverse effects. Asenapine might be effective for treating patients with schizophrenia who experience olanzapine-induced weight gain.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 33%
Researcher 1 17%
Student > Bachelor 1 17%
Student > Master 1 17%
Unspecified 1 17%
Other 0 0%
Readers by discipline Count As %
Unspecified 3 50%
Psychology 2 33%
Medicine and Dentistry 1 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2018.
All research outputs
#7,064,396
of 12,517,383 outputs
Outputs from Neuropsychiatric Disease and Treatment
#960
of 2,120 outputs
Outputs of similar age
#173,046
of 381,596 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#33
of 68 outputs
Altmetric has tracked 12,517,383 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,120 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,596 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.